news
People with type 2 diabetes experience greater improvements in glycaemic control when using Victoza®
13 September 2011 | By Novo Nordisk
Patient satisfaction when switching from sitagliptin to Victoza®...
List view / Grid view
Novo Nordisk
news
Novo Nordisk to build new corporate centre
25 August 2011 | By Novo Nordisk
Novo Nordisk is investing around 1 billion Danish kroner (134 million euros) in two new office buildings with surrounding green space in Bagsværd, Denmark...
news
Investigational ultra-long-acting insulin degludec reduces hypoglycaemia and improves long-term control
27 July 2011 | By Novo Nordisk
Ultra-long-acting insulin degludec, lowers blood glucose levels...
news
Novo Nordisk gains EU approval for FlexTouch®
14 July 2011 | By Novo Nordisk
Novo Nordisk has been granted approval by the European Commission for the new prefilled insulin pen – FlexTouch®...
news
Investigational ultra-long-acting insulin degludec reduces hypoglycaemia
27 June 2011 | By Novo Nordisk
Ultra-long-acting insulin degludec, lowers blood glucose levels with significantly reduced rates of hypoglycaemia (low blood sugar)...
news
Novo Nordisk invests 1 billion Danish kroner in new factory in Denmark
22 June 2011 | By Novo Nordisk
Novo Nordisk is investing close to 1 billion Danish kroner (134 million euros) in a new factory in Kalundborg, Denmark...
news
EMD Millipore announces change in supply chain of insulin for cell culture media
25 January 2011 | By Novo Nordisk
EMD Millipore, announced an agreement with Novo Nordisk, to transfer the distribution of recombinant human insulin for cell culture media...
article
HVAC energy savings in the pharmaceutical industry
23 November 2007 | By
Proper and compliant HVAC systems are fundamental to the pharma industry as we use high air change rates to secure a low viable and particle contamination. HVAC is energy consuming and therefore the HVAC accounts for a large proportion of the energy used in pharma facilities. In the past the…
